K. Neuthe et al. / Dyes and Pigments 104 (2014) 24e33
27
2.3.3. Complexes
(d, J ¼ 5.8 Hz, 1H), 7.64 (d, J ¼ 5.0 Hz,1H). HRMS (ESI) m/z: [M ꢁ Cl]þ
calcd. for (C24H16ClN4O8Ru-) 477.0056; found 477.0128.
Bi- and trileptic ruthenium(II) complexes were synthesized by
modification of literature procedures [14,15,16,17].
In a ethanol/water (1:1) mixture RuCl2dcbpy2 14 and mpabpy 12
were first stirred for 12 h at 100 ꢂC, and then for 12 h at r.t. ethanol
was removed under reduced pressure and water added. A yellow
precipitate formed which was removed by filtration. The red filtrate
was extracted with DCM. The aqueous layer was concentrated in
vacuo and the resulting residue purified by HPLC (RP-18, 12.5 cm,
RSC, 1.5 mL minꢁ1, 450 nm, 60/40 water/acetone with 0.6% acetic
acid). Acetonitrile was removed under reduced pressure and the
product precipitated from the acidic solution (pH ¼ 2). Filtration
yielded the complex 3 as a red solid (46.8 mg, 0.046 mmol, 10.0%).
2.3.3.1. [Ru(bpy)2(dpbpy)], 1. To 2,20-bipyridine (2.00 g, 12.8 mmol,
2.00 equiv.), dissolved in degassed DMF, under argon, and shielded
from light, LiCl (1.90 g, 44.8 mmol, 7.0 equiv.) and RuCl3∙H2O
(1.33 g, 6.41 mmol, 1.0 equiv.) were added. The resulting mixture
was first stirred for 24 h at 175 ꢂC, and then for 12 h at r.t. DMF was
removed in vacuo and an excess of acetone was added to the res-
idue. The solution was kept for 1e2 d at ꢁ12 ꢂC. A precipitate
formed, which was collected by filtration and washed with 3 por-
tions of cold acetone, yielding ruthenium precursor RuCl2bpy2 (13)
as dark crystals (1.12 g, 2.31 mmol, 38.0%). 1H NMR (700 MHz;
1H NMR (500 MHz, CD3OD: CD3CN ¼ 2:1):
in ppm ¼ 9.14 (m, 2H),
d
8.76 (s, 1H), 8.67 (s,1H), 8.61 (s,1H), 8.40 (s,1H), 8.07 (d, J ¼ 5.8,1H),
8.01 (d, J ¼ 5.8, 1H), 7.97e7.95 (m, 2H), 7.90 (s, 1H), 7.89 (s, 1H), 7.86
(s, 1H), 7.83 (s, 1H), 7.73 (d, J ¼ 16.3, 1H), 7.62e7.60 (m, 2H), 7.57e
7.55 (m, 2H), 7.50 (d, J ¼ 6.1, 1H), 7.39 (s, 1H), 7.36 (d, J ¼ 7.5, 4H),
7.34 (s, 1H), 7.25 (d, J ¼ 16.3, 1H), 7.18 (s, 1H), 7.15 (m, 5H), 7.12 (t,
J ¼ 1.1 Hz, 1H), 7.02 (dd, J ¼ 8.6, 5.3 Hz, 2H), 2.60 (s, 3H). HRMS (ESI)
m/z: [M ꢁ H]ꢁ1: calcd. for (C55H38N7O8Ruꢁ): 1026.1846; found
1026.1913.
DMSO-d6):
d
in ppm ¼ 9.98 (d, J ¼ 5.6 Hz, 2H), 8.64 (d, J ¼ 8.2 Hz,
2H), 8.48 (d, J ¼ 8.3 Hz, 2H), 8.06 (t, J ¼ 7.8 Hz, 2H), 7.77 (t, J ¼ 6.6 Hz,
2H), 7.68 (t, J ¼ 7.8 Hz, 2H), 7.51 (d, J ¼ 5.1 Hz, 2H), 7.10 (t, J ¼ 6.6 Hz,
2H), HRMS (ESI) m/z: [M ꢁ Cl þ CO]þ calcd. for (C21H16ClN4ORu)
477.0056; found 477.0128.
To RuCl2bpy2 13 (20.0 mg, 0.041, 1.00 equiv.) dissolved in water
(15 mL) 2,20-Bipyridine-4,40-diphosphonic acid
7
(20 mg,
0.041 mmol, 1.0 equiv.) was added and was heated under reflux for
18 h. The solvent was removed in vacuo and an excess of acetone
was added. The resulting solution was kept for 1e2 d at ꢁ12 ꢂC. A
precipitate formed, which was filtered and washed with cold
acetone (3 ꢃ 15 mL) to give [Ru(bpy)2(dpbpy)] 1 as dark brown
crystals (15.3 mg, 0.021 mmol, 51.1%). 1H NMR (700 MHz; DMSO-
2.3.3.4. [Ru(dnbpy)(dpbpy)Cl2], 4. To Dichloro-p-cymene ruthe-
nium dimer (0.050 g, 0.090 mmol, 1.00 equiv.) dissolved in dry,
degassed DMF (20 mL), under argon, and shielded from light was
added donor ligand dnbpy 10 (0.073 g, 0.180 mmol, 2.00 equiv.).
The mixture was stirred at 75 ꢂC for 5 h, cooled to room tem-
perature, and stirred for 12 h. After adding dpbpy 7 (0.150 g,
0.360 mmol, 4 equiv.) the reaction mixture was refluxed for 4 h
resulting in a dark-red solution. The solvent was removed in
vacuo and the crude product purified by size exclusion chroma-
tography on a Sephadex LH-20 column using water. Aqueous HCl
(6 M, 25 mL) was added to the main fraction and the resulting
solution was refluxed for 15 h. The black solution was purified by
size exclusion chromatography on a Sephadex LH-20 yielding 4
d6):
d
in ppm ¼ 8.95 (s, 2H, H-30; H-37), 8.84 (d, J ¼ 8.3 Hz, 4H, H-5;
H-12; H-17; H-24), 8.19e8.15 (m, 4H, H-2; H-9; H-14; H-21), 7.86
(dd, J ¼ 5.4, 3.2 Hz, 2H, H-27; H-34), 7.77 (d, J ¼ 5.3 Hz, 2H), 7.71 (d,
J ¼ 5.3 Hz, 2H), 7.64 (ddd, J ¼ 11.7, 5.7,1.2 Hz, 2H; H-26; H-35), 7.55e
7.51 (m, 4H, H-1; H-10; H-13; H-22).
2.3.3.2. [Ru(mpabpy)(dpbpy)2], 2. Dichloro-p-cymene ruthenium
dimer (27.6 mg, 0.045 mmol, 1.00 equiv.) dissolved in dry DCM
(20 mL), under argon, shielded from light by aluminum foil, was
reacted with mpabpy 12 (39.60 mg, 0.090 mmol, 2.00 equiv.) at r.t.
for 12 h. DCM was removed in vacuo to afford the corresponding
[RuCymClL] precursor with L ¼ mpabpy as a red solid (61.6 mg,
95.6%).
(40.0 mg, 0.045 mmol, 28.0%). 1H NMR (500 MHz, CD3OD):
d in
ppm ¼ 8.60 (s, 4H), 7.66 (s, 4H), 7.40 (s, 2H), 7.33 (s, 2H), 4.02e
4.01 (m, 2H), 2.84 (t, J ¼ 5.8, 2H), 1.82e1.69 (m, 4H), 1.39e1.20 (m,
24H). 0.88 (t, J ¼ 6.5, 6H). HRMS (ESI) m/z: [M ꢁ Cl]þ: calcd. for
(C39H57ClN4O6P2Ruꢁ): 876.25.; found 876.28.
To the [RuCymClL] precursor (44.6 mg, 0.063 mmol,1.00 equiv.),
dissolved in distilled water (20.0 mL), under argon, shielded from
light by aluminum foil, dpbpy 7 (39.9 mg, 0.126 mmol, 2.00 equiv.)
was added. After refluxing for 24 h the dark red solution was
poured into DCM and extracted with a water/methanol (1:1)
mixture. After freeze-drying, ruthenium complex 2 was received as
a red powder (39.3 mg, 0.034 mmol, 53.3%). 1H NMR (700 MHz;
2.3.3.5. [Ru(dnbpy)(dmdpbpy) 2], 5. To Dichloro-p-cymene ruthe-
nium dimer (0.050 g, 0.090 mmol, 1.00 equiv.) dissolved in dry,
degassed DMF (20 mL), under argon, and shielded from light
donor ligand dnbpy 10 (0.073 g, 0.180 mmol, 2.00 equiv.) was
added. The mixture was stirred at 75 ꢂC for 5 h, cooled to room
temperature and stirred for 12 h. After adding anchor dmdpbpy 9
(0.160 g, 0.36 mmol, 4.00 equiv.) the reaction mixture was
refluxed for 4 h resulting in a dark-red solution. The solvent was
removed in vacuo and the crude product purified on a Sephadex
LH-20 column using water. Aqueous HCl (6 M, 25 mL) was added
to the main fraction and the resulting mixture was refluxed until
IR measurements confirmed disappearance of the P-O-alkyl
signal (1000e920 cmꢁ1). The crude product was purified by size
MeOD-d4):
d
in ppm ¼ 8.87 (s, 1H, H-12), 8.85 (s, 1H, H-2), 8.69 (d,
J ¼ 12.8 Hz, 5H, H-9; H-24; H-31; H-38; H-45), 8.66 (t, J ¼ 4.4 Hz, 5H,
H-5; H-27; H-34; H-41; H-48), 7.84 (dd, J ¼ 5.4, 2.9 Hz, 1H, H-4),
7.75 (dd, J ¼ 11.7, 4.7 Hz, 6H, H-17; H-21; H-23; H-32; H-37; H-46),
7.73e7.68 (m, 4H, H-55; H-57; H-60; H-62), 7.59e7.51 (m, 2H, H-10;
H-15), 7.34e6.97 (m, 9H, H-14; H-18; H-20; H-54; H-56; H-58; H-
59; H-61; H-63), 2.69 (s, 3H, CH3). 31P NMR (500 MHz; MeOD-d4):
d
in ppm ¼ 7.60 (s), 4.83 (d, J ¼ 32.7 Hz), 4.61 (s). HRMS (ESI) m/z:
[M calcd. for (C51H41N7O12P4Ru): 1170.0874; found
H]ꢁ1
1170.0701.
ꢁ
:
exclusion chromatography on a Sephadex LH-20 yielding
5
(160.0 mg, 0.134 mmol, 96.0%). 1H NMR (700 MHz, CD3OD):
d
in
ppm 8.63 (s, 5H), 7.68 (s, 5H), 7.42 (s, 4H), 7.34 (s, 2H), 2.89e2.83
(m, 4H), 1.78e1.73 (m, 4H), 1.46e1.22 (m, 24H), 0.93e0.87 (m,
2.3.3.3. [Ru(mdpabpy)(dcbpy)2],
3. Ruthenium
precursor
RuCl2dcbpy2 14 was prepared in the same manner as described for
precursor 13 and was obtained as black crystals (0.530 g,
6H). 31P NMR (400 MHz; MeOD-d4):
d
in ppm ¼ 21.07 (s). HRMS
(ESI) m/z: [M þ Li]þ: calcd. for (C70H72LiN6O12P4Ruþ): 1205.34.;
found 1205.8228. Anal. Calcd for RuC52H70N6O12P4: H, 6.06; C,
52.13; N, 7.01. Found: H, 6.69; C, 51.23; N, 6.05. IR (max, solid):
0.803 mmol, 79%). 1H NMR (700 MHz; MeOD-d4):
d
in ppm ¼
d 9.61
(d, J ¼ 5.3 Hz, 1H), 9.45 (d, J ¼ 5.5 Hz, 1H), 9.08e9.06 (m, 4h), 7.89 (s,
1H), 7.88 (s, 1H), 7.87 (d, J ¼ 1.6 Hz, 1H), 7.86 (d, J ¼ 1.7 Hz, 0H), 7.83
2921 n(CH3), 2850 n(HeOeP]O).